(Q44357049)

2 December 2017

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast (English)

1 reference

2 December 2017

1 reference

3

1 reference

2 December 2017

2

Hopper JL

1 reference

2 December 2017

Provenzano E

1

1 reference

2 December 2017

Marr G

series ordinal

4

1 reference

2 December 2017

Venter DJ

series ordinal

5

1 reference

2 December 2017

Armes JE

series ordinal

6

1 reference

2 December 2017

1 March 2003

1 reference

European Journal of Cancer

2 December 2017

1 reference

2 December 2017

39

1 reference

2 December 2017

5

1 reference

2 December 2017

622-630

1 reference

Incidence of and treatment for ductal carcinoma in situ of the breast.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

The Diagnosis and Treatment of Ductal Carcinoma In Situ of the Breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Overview of the biology and management of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

A prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

p21(WAF1) expression and endocrine response in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900666-4

7 January 2021

10.1016/S0959-8049(02)00666-4

Identifiers

DOI

1 reference

2 December 2017

1 reference